Report cover image

Europe Mid-Size Pharmaceutical Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Prescription and Over-the-Counter), Drug Development Type (In-House and Outsource), Formulation (Tablets and Capsules, Injectables, Sprays, and Other

Publisher The Insight Partners
Published Sep 23, 2022
Length 73 Pages
SKU # TIP17466369

Description

Europe Mid-Size Pharmaceutical Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Prescription and Over-the-Counter), Drug Development Type (In-House and Outsource), Formulation (Tablets and Capsules, Injectables, Sprays, and Other Formulations), and Therapy Class (Cardiovascular Diseases, Pain Management, Diabetes, Cancer, and Other Conditions)    

The mid-size pharmaceutical market in Europe is expected to grow from US$ 201,707.89 million in 2022 to US$ 288,168.27 million by 2028; it is estimated to grow at a CAGR of 6.1% from 2022 to 2028.
The mid-size pharmaceutical market in Europe is characterized by the presence of various market players. To increase their market share, the players adopt various strategies such as product launches, regional expansion, and technological advancements. Leading players invest in R&D to develop advanced technologies and gain revenue. Europe accounts for the second-largest market share and is anticipated to register a significant growth rate over the forecast period. The market growth in this region is attributed to the increasing number of product launches and the growing prevalence of chronic diseases. Further, increased government expenditures on the healthcare sector favor the entry of new players in the mid-size pharmaceutical market in this region. However, the cutthroat competition among market players hinders the market growth.
By introducing new features and technologies, vendors in the Europe mid-size pharmaceutical market can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the market growth at a good CAGR during the forecast period.
Europe Mid-Size Pharmaceutical Market Revenue and Forecast to 2028 (US$ Million)
Europe Mid-Size Pharmaceutical Market Segmentation
The Europe mid-size pharmaceutical market is segmented on the basis of type, drug development type, formulation, therapy class, and country.
Based on type, the Europe mid-size pharmaceutical market is bifurcated into prescription and over-the-counter. In 2022, the over-the-counter segment accounted for a larger market share. Based on drug development type, the market is bifurcated into in-house and outsource. The outsource segment held a larger market share in 2022. Based on formulation, the Europe mid-size pharmaceutical market is segmented into tablets and capsules, injectables, sprays, and other formulations. The tablets & capsules segment held the largest market share in 2022. Based on therapy class, the market is segmented into cardiovascular diseases, pain management, diabetes, cancer, and other conditions. The diabetes segment held the largest market share in 2022. Based on country, the Europe mid-size pharmaceutical market is segmented into Germany, France, the UK, Italy, Spain, and Rest of Europe. Germany held the largest market share in 2022.
Alexion Pharmaceuticals, Inc.; Bausch Health Companies Inc.; Daiichi Sankyo Company Limited; Eisai Co., Ltd.; Endo Pharmaceuticals Inc.; Les Laboratories Servier; Mallinckrodt; Regeneron Pharmaceuticals, Inc; Sun Pharmaceutical Industries Ltd; and UCB S.A. are among the leading companies operating in the mid-size pharmaceutical market in the region.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe mid-size pharmaceutical market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe mid-size pharmaceutical market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the mid-size pharmaceutical market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution"

Table of Contents

73 Pages
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Mid-Size Pharmaceutical – By Type
1.3.2 Europe Mid-Size Pharmaceutical – By Drug Development Type
1.3.3 Europe Mid-Size Pharmaceutical – By Formulation
1.3.4 Europe Mid-Size Pharmaceutical – By Therapy Area
1.3.5 Europe Mid-Size Pharmaceutical – By Country
2. Mid-Size Pharmaceutical– Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Mid-Size Pharmaceutical – Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Expert Opinion
5. Mid-Size Pharmaceutical Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Chronic Disorders
5.1.2 Increasing Product Approval and Launches
5.2 Market Restraints
5.2.1 Cutthroat Competition among Market Players
5.3 Market Opportunities
5.3.1 Rising Number of Healthcare Start-ups
5.4 Future Trends
5.4.1 Greater Focus on R&D
5.5 Impact Analysis
6. Mid-Size Pharmaceutical Market– Europe Analysis
6.1 Europe Mid-Size Pharmaceutical Market Revenue Forecast and Analysis
7. Europe Mid-Size Pharmaceutical Market Revenue and Forecasts To 2028– by Type
7.1 Overview
7.2 Europe Mid-Size Pharmaceutical Market Revenue Share, by Type (2022 and 2028)
7.3 Prescription
7.3.1 Overview
7.3.2 Prescription: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Over-the-Counter (OTC)
7.4.1 Overview
7.4.2 Over-the-Counter: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
8. Europe Mid-Size Pharmaceutical Market Analysis – By Drug Development Type
8.1 Overview
8.2 Europe Mid-Size Pharmaceutical Market Revenue Share, by Drug Development Type (2022 and 2028)
8.3 In-House
8.3.1 Overview
8.3.2 In-House: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Outsource
8.4.1 Overview
8.4.2 Outsource: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe Mid-Size Pharmaceutical Market – By Formulation
9.1 Overview
9.2 Europe Mid-Size Pharmaceutical Market, by Formulation, 2022 and 2028 (%)
9.3 Tablets and Capsules
9.3.1 Overview
9.3.2 Tablets and Capsules: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Injectables
9.4.1 Overview
9.4.2 Injectables: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Sprays
9.5.1 Overview
9.5.2 Sprays: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Other Formulations
9.6.1 Overview
9.6.2 Others: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
10. Europe Mid-Size Pharmaceutical Market – By Therapy Class
10.1 Overview
10.2 Europe Mid-Size Pharmaceutical Market, by Therapy Class, 2022 and 2028 (%)
10.3 Cardiovascular Diseases
10.3.1 Overview
10.3.2 Cardiovascular Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Pain Management
10.4.1 Overview
10.4.2 Pain Management: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
10.5 Diabetes
10.5.1 Overview
10.5.2 Diabetes: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
10.6 Cancer
10.6.1 Overview
10.6.2 Cancer: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
10.7 Other Diseases
10.7.1 Overview
10.7.2 Other Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11. Europe Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 – Country Analysis
11.1 Overview
11.1.1 Europe: Mid-Size Pharmaceutical Market, by Country, 2021 & 2028 (%)
11.1.1.1 Germany: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.1 Overview
11.1.1.1.2 Germany: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.3 Germany: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.4 Germany: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.5 Germany: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.6 Germany: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2 France: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.1 Overview
11.1.1.2.2 France: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.3 France: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.4 France: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.5 France: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.6 France: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3 UK: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.1 Overview
11.1.1.3.2 UK: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.3 UK: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.4 UK: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.5 UK: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.6 UK: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
11.1.1.4 Italy: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.4.1 Overview
11.1.1.4.2 Italy: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.4.3 Italy: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
11.1.1.4.4 Italy: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
11.1.1.4.5 Italy: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
11.1.1.4.6 Italy: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
11.1.1.5 Spain: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.5.1 Overview
11.1.1.5.2 Spain: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.5.3 Spain: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
11.1.1.5.4 Spain: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
11.1.1.5.5 Spain: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
11.1.1.5.6 Spain: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
11.1.1.6 Rest of Europe: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.6.1 Overview
11.1.1.6.2 Rest of Europe: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.6.3 Rest of Europe: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
11.1.1.6.4 Rest of Europe: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
11.1.1.6.5 Rest of Europe: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
11.1.1.6.6 Rest of Europe: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
12. Mid-Size Pharmaceutical Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 DAIICHI SANKYO COMPANY LIMITED
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Eisai Co., Ltd.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Bausch Health Companies Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Regeneron Pharmaceuticals, Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Sun Pharmaceutical Industries Ltd
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Alexion Pharmaceuticals, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Mallinckrodt
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Endo Pharmaceuticals Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Les Laboratories Servier
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 UCB S.A.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Germany: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. Germany: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
Table 3. Germany: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 4. Germany: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
Table 5. France: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 6. France: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
Table 7. France: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 8. France: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
Table 9. UK: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 10. UK: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
Table 11. UK: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 12. UK: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
Table 13. Italy: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. Italy: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
Table 15. Italy: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 16. Italy: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
Table 17. Spain: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 18. Spain: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
Table 19. Spain: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 20. Spain: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
Table 21. Rest of Europe: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 22. Rest of Europe: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
Table 23. Rest of Europe: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 24. Rest of Europe: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
Table 25. Organic Developments Done By Companies
Table 26. Inorganic Developments Done By Companies
Table 27. Glossary of Terms
 
LIST OF FIGURES
Figure 1. Europe Mid-Size Pharmaceutical Segmentation
Figure 2. Europe Mid-Size Pharmaceutical Segmentation, By Country
Figure 3. Europe Mid-Size Pharmaceutical Overview
Figure 4. Over-the-Counter Segment Held Largest Share by Type in Europe Mid-Size Pharmaceutical Market
Figure 5. Germany Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Europe: PEST Analysis
Figure 7. Europe Mid-Size Pharmaceutical Market– Revenue Forecast And Analysis – 2020- 2028
Figure 8. Europe Mid-Size Pharmaceutical Market Revenue Share, by Type (2022 and 2028)
Figure 9. Europe Prescription: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. Europe Over-the-Counter: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Europe Mid-Size Pharmaceutical Market Revenue Share, by Drug Development Type (2022 and 2028)
Figure 12. Europe In-House: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Europe Outsource: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Europe Mid-Size Pharmaceutical Market, by Formulation, 2022 and 2028 (%)
Figure 15. Europe Tablets and Capsules: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Europe Injectables: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Europe Sprays: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Europe Others: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Europe Mid-Size Pharmaceutical Market, by Therapy Class, 2022 and 2028 (%)
Figure 20. Europe Cardiovascular Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Europe Pain Management: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Europe Diabetes: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Europe Cancer: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Europe Other Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Europe: Mid-Size Pharmaceutical Market, by Key Country – Revenue (2021) (US$ Million)
Figure 26. Europe: Mid-Size Pharmaceutical Market, by Country, 2021 & 2028 (%)
Figure 27. Percentage of people aged 65+ reporting chronic diseases are as follows: (Source: European Commission (2019a), Joint report on health care)
Figure 28. Germany: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. France: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. UK: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Italy: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Spain: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Rest of Europe: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Growth Strategies Done by the Companies in the Market, (%)
 

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us